Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma
BMC Urology Sep 12, 2017
Pilskog M, et al. - Keeping the objective in mind, researchers demonstrated that baseline C-reactive protein was a significant predictive factor of sunitinib response and a prognostic factor of survival. It was considered that baseline C-reactive protein might be a useful biomarker in the treatment planning of metastatic renal clear cell carcinoma. Due to the relatively small sample size, the outcomes need to be confirmed in larger studies.Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free.
55 lakhs+ doctors trust M3 globally
Unlimited access to original articles by experts
Secure: we never sell your data
Signing up takes less than 2 mins